News Column

New Colon Cancer Data Have Been Reported by D. Peiffert and Co-Authors

May 19, 2014

By a News Reporter-Staff News Editor at Robotics & Machine Learning -- Data detailed on Oncology have been presented. According to news originating from Vandoeuvre les Nancy, France, by VerticalNews correspondents, research stated, "Cyberknife is a dedicated stereotactic radiotherapy device. This new technology permits precise delivery of high dose gradient radiation therapy while sparing the surrounding organs at risk."

Our news journalists obtained a quote from the research, "Hepatic metastases of colorectal cancer (HMCRC) are an example of a lesion where treatment with Cyberknife r is indicated because they are located in a radiosensitive organ and curative treatment is based on focal eradication (resection, radiofrequency ablation,...). The local control rate at one year is reported to be 70 to 100% depending on the study. Tolerance is excellent with less than a 5% rate of acute grade 3 or 4 side effects (nausea, vomiting, gastro-duodenal ulcer). The specific hepatotoxicity of radiotherapy, so-called radiation-induced liver disease (RILD), was found in only one study. Candidates for stereotactic radiotherapy are patients in whom disease is controlled except for intrahepatic disease with 1-3 hepatic metastases = 700 cm(3) and normal liver function. It is actually a very simple treatment that results in very good local control with few contraindications."

According to the news editors, the research concluded: "Its place in the management strategy of liver metastases needs further clarification."

For more information on this research see: Treatment of hepatic metastases of colorectal cancer by robotic stereotactic radiation (Cyberknife ). Journal of Visceral Surgery, 2014;151():S45-S49. Journal of Visceral Surgery can be contacted at: Elsevier Masson, Via Paleocapa 7, 20121 Milano, Italy. (Elsevier -; Journal of Visceral Surgery -

The news correspondents report that additional information may be obtained from D. Peiffert, Inst Cancerol Lorraine, F-54519 Vandoeuvre Les Nancy, France. Additional authors for this research include A.S. Baumann and V. Marchesi.

Keywords for this news article include: France, Europe, Oncology, Robotics, Colorectal, Colon Cancer, Radiotherapy, Gastroenterology, Machine Learning, Radiation Therapy, Vandoeuvre les Nancy, Emerging Technologies

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Robotics & Machine Learning

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters